Skip to main content
. 2011 Apr;52(4):794–800. doi: 10.1194/jlr.M011163

Fig. 2.

Fig. 2.

Compartment model describes apoC-III tracer kinetics. Leucine tracer is injected into plasma (compartment 2) and distributes to extravascular compartments (compartments 1, 3, and 4). Compartments 14 are required to describe leucine tracer kinetics observed in plasma. Compartment 1 is connected to an intracellular delay compartment (compartment 5) that account for the synthesis, assembly, and secretion of apoC-III. Compartment 6 describes the kinetics of plasma apoC-III.